Showing 1311-1320 of 1395 results for "".
- Slit Lamp Breath Shields Proven to Minimize Spread of Droplets That Can Carry Coronavirus During Eye Examshttps://modernod.com/news/slit-lamp-breath-shields-proven-to-minimize-spread-of-droplets-that-can-carry-coronavirus-during-eye-exams/2478567/Eye exams require close physical contact between patients and physicians, which is not an issue, until a pandemic strikes. Last spring, ophthalmologists began improvising with various forms and sizes of plastic sheeting attached to exam equipment to help protect both the patient and them from the
- AstraZeneca Must Explain Spinal Ailment to Resume Vaccine Trialhttps://modernod.com/news/astrazeneca-must-explain-spinal-ailment-to-resume-vaccine-trial/2478268/A day after pausing its COVID-19 vaccine trials due to a possible serious neurological problem in one patient, AstraZeneca faced numerous questions about what exactly caused the issue and whether it could be related to the vaccine, according to a Bloomberg News
- AstraZeneca Pauses COVID-19 Vaccine Trial Amid Safety Concernhttps://modernod.com/news/astrazeneca-pauses-covid-19-vaccine-trial-amid-safety-concern/2478258/Shares in AstraZeneca fell as much as 6% on Tuesday after the company confirmed that a phase 3 trial of its experimental COVID-19 vaccine AZD1222 has been put on hold due to a possible safety issue. AstraZeneca called the move “a routine action which has to happen whenever there is a potent
- NIH Panel Finds “Insufficient” Data to Support Use of Plasma for COVID-19https://modernod.com/news/nih-panel-finds-insufficient-data-to-support-use-of-plasma-for-covid-19/2478235/A panel of the National Institutes of Health (NIH) concluded that “there are insufficient data to recommend either for or against the use of convalescent plasma for the treatment of COVID-19.” The review by the COVID-19 Treatment Guidelines Panel comes shortly after the FDA issued an
- Health Canada Authorizes Enspryng for Canadians Living with Neuromyelitis Optica Spectrum Disorderhttps://modernod.com/news/health-canada-authorizes-enspryng-for-canadians-living-with-neuromyelitis-optica-spectrum-disorder/2478219/Roche Canada announced that Health Canada has granted market authorization for Enspryng (satralizumab) as monotherapy or in combination with immunosuppressive therapy (IST) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult and adolescent patients who are anti-aqu
- Clearside Biomedical Expands Patent Portfolio in the US and Europehttps://modernod.com/news/clearside-biomedical-expands-patent-portfolio-in-the-us-and-europe/2478203/Clearside Biomedical announced the recent issuance of three additional patents in the United States and Europe. The United States Patent and Trademark Office (USPTO) recently granted patent number 10,722,396 to Clearside. This patent covers Clearside’s SCS M
- AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its XLRP Gene Therapy Programhttps://modernod.com/news/agtc-announces-publication-of-preclinical-data-that-support-the-ongoing-clinical-development-of-its-xlrp-gene-therapy-program/2478200/Applied Genetic Technologies Corporation (AGTC) announced that preclinical data validating the transgene (hRPGRco) that is being evaluated in the company’s ongoing phase 1/2 clinical trial in patients with X-lined retinitis pigmentosa (XLRP) have been published in the July 15, 2020 print issue of
- BVI Partners With HVO to Provide PPE for Healthcare Workershttps://modernod.com/news/bvi-partners-with-hvo-to-provide-ppe-for-healthcare-workers/2478155/BVI has partnered with Haywood Vocational Opportunities (HVO) to provide isolation gowns to US healthcare workers on the front lines of the pandemic effort. HVO is a US based medical product manufacturer who provides vocational training and employment opportunities for adults with disadva
- Alcon Canada introduces PRECISION1 Contact Lenseshttps://modernod.com/news/alcon-canada-introduces-precision1-contact-lenses/2478144/Alcon has launched the PRECISION1 daily disposable, silicone hydrogel (SiHy) contact lenses in Canada. Designed to address the common issues that cause 1-in-5 new wearers to discontinue contact lens within the first year (poor vision, comfort and handling issues1), Precision1 he
- New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals’ Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asiahttps://modernod.com/news/new-licensing-agreement-accelerates-the-development-of-iacta-pharmaceuticals-novel-dry-eye-disease-and-allergic-conjunctivitis-treatments-in-china-and-southeast-asia/2478088/IACTA Pharmaceuticals and Zhaoke Ophthalmology Pharmaceutical (ZKO), a Hong Kong-based pharmaceutical company, announced they have entered into a definitive license agreement on the licensing of two of the company’s products, IC 265 for dry eye and IC 270 fo